• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections.可能将桧木醇用作天然锌载体和抗感染剂,用于预防和治疗 COVID-19 和病毒感染。
Med Hypotheses. 2020 Dec;145:110333. doi: 10.1016/j.mehy.2020.110333. Epub 2020 Oct 5.
2
Inhibition of SARS-CoV-2 replication by zinc gluconate in combination with hinokitiol.葡萄糖酸锌联合桧木醇抑制 SARS-CoV-2 复制。
J Inorg Biochem. 2022 Jun;231:111777. doi: 10.1016/j.jinorgbio.2022.111777. Epub 2022 Mar 1.
3
Antiviral activity of the zinc ionophores pyrithione and hinokitiol against picornavirus infections.锌离子载体吡啶硫酮和扁柏酚对小核糖核酸病毒感染的抗病毒活性。
J Virol. 2009 Jan;83(1):58-64. doi: 10.1128/JVI.01543-08. Epub 2008 Oct 15.
4
Treatment of severe pneumonia by hinokitiol in a murine antimicrobial-resistant pneumococcal pneumonia model.用桧醇治疗耐抗生素肺炎链球菌肺炎小鼠模型中的重症肺炎。
PLoS One. 2020 Oct 15;15(10):e0240329. doi: 10.1371/journal.pone.0240329. eCollection 2020.
5
Antibacterial effect of beta-thujaplicin on staphylococci isolated from atopic dermatitis: relationship between changes in the number of viable bacterial cells and clinical improvement in an eczematous lesion of atopic dermatitis.β-崖柏素对从特应性皮炎分离出的葡萄球菌的抗菌作用:特应性皮炎湿疹病变中活菌细胞数量变化与临床改善之间的关系。
J Antimicrob Chemother. 2003 Jan;51(1):113-22. doi: 10.1093/jac/dkg037.
6
Antimicrobial activity and metalloprotease inhibition of hinokitiol-related compounds, the constituents of Thujopsis dolabrata S. and Z. hondai MAK.扁柏醇相关化合物(日本扁柏和台湾扁柏的成分)的抗菌活性及金属蛋白酶抑制作用
Biol Pharm Bull. 1999 Sep;22(9):990-3. doi: 10.1248/bpb.22.990.
7
Effect of mouth cleaning with hinokitiol-containing gel on oral malodor: a randomized, open-label pilot study.含丁香酚凝胶对口臭的清洁效果:一项随机、开放标签的初步研究。
Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 Oct;116(4):433-9. doi: 10.1016/j.oooo.2013.05.021. Epub 2013 Aug 19.
8
Does zinc supplementation enhance the clinical efficacy of chloroquine/hydroxychloroquine to win today's battle against COVID-19?补锌能否增强氯喹/羟氯喹的临床疗效,赢得抗击 COVID-19 的今天?
Med Hypotheses. 2020 Sep;142:109815. doi: 10.1016/j.mehy.2020.109815. Epub 2020 May 6.
9
Transmission electron microscopy of Schistosoma mansoni cercariae treated with hinokitiol (beta-thujaplicin), a compound for potential skin application against cercarial penetration.用扁柏酚(β-崖柏素)处理曼氏血吸虫尾蚴的透射电子显微镜观察,扁柏酚是一种有望用于皮肤以防止尾蚴侵入的化合物。
Tohoku J Exp Med. 2004 Jan;202(1):63-7. doi: 10.1620/tjem.202.63.
10
Evaluation physical characteristics and comparison antimicrobial and anti-inflammation potentials of dental root canal sealers containing hinokitiol in vitro.体外评估含扁柏酚的牙根管封闭剂的物理特性及其抗菌和抗炎潜力的比较。
PLoS One. 2014 Jun 10;9(6):e94941. doi: 10.1371/journal.pone.0094941. eCollection 2014.

引用本文的文献

1
Studies on the antifungal effects of Hinokitiol on Candida albicans: inhibition of germ tube formation and synergistic pharmacological effects of miconazole.扁柏酚对白色念珠菌的抗真菌作用研究:对芽管形成的抑制及与咪康唑的协同药理作用
Odontology. 2025 Apr;113(2):556-565. doi: 10.1007/s10266-024-00992-4. Epub 2024 Sep 18.
2
Static Magnetic Field Reduces the Anticancer Effect of Hinokitiol on Melanoma Malignant Cells-Gene Expression and Redox Homeostasis Studies.静磁场降低了扁柏酚对黑色素瘤恶性细胞的抗癌作用——基因表达与氧化还原稳态研究
Pharmaceuticals (Basel). 2024 Mar 27;17(4):430. doi: 10.3390/ph17040430.
3
Natural Compounds with Antifungal Properties against and Identification of Hinokitiol as a Promising Antifungal Drug.具有抗真菌特性的天然化合物以及扁柏酚作为一种有前景的抗真菌药物的鉴定。
Antibiotics (Basel). 2023 Nov 8;12(11):1603. doi: 10.3390/antibiotics12111603.
4
A Prospective Study of AFree Oral Spray as an Adjuvant Therapy for Mild and Moderate COVID-19 in Community Health Stations: Clinical Progression and Viral Clearance Outcomes.一项在社区卫生服务站中使用 AFree 口腔喷雾作为轻度和中度 COVID-19 辅助治疗的前瞻性研究:临床进展和病毒清除结局。
In Vivo. 2023 Sep-Oct;37(5):2155-2160. doi: 10.21873/invivo.13313.
5
Therapeutic Efficacy of AFree Oral Spray on the Symptoms and Course of Moderate and Severe COVID-19 in the Field Hospital.野战医院中 AFree 口腔喷雾对中重度 COVID-19 症状和病程的治疗效果。
In Vivo. 2023 Jul-Aug;37(4):1743-1750. doi: 10.21873/invivo.13262.
6
Curcumin attenuates hydroxychloroquine-mediated apoptosis and oxidative stress via the inhibition of TRPM2 channel signalling pathways in a retinal pigment epithelium cell line.姜黄素通过抑制视网膜色素上皮细胞系中的 TRPM2 通道信号通路来减轻羟氯喹介导的细胞凋亡和氧化应激。
Graefes Arch Clin Exp Ophthalmol. 2023 Oct;261(10):2829-2844. doi: 10.1007/s00417-023-06082-5. Epub 2023 Apr 26.
7
Zinc and selenium status in coronavirus disease 2019.新型冠状病毒疾病 2019 中锌和硒的状态。
Biometals. 2023 Oct;36(5):929-941. doi: 10.1007/s10534-023-00501-0. Epub 2023 Apr 20.
8
Hinokitiol Selectively Enhances the Antibacterial Activity of Tetracyclines against Staphylococcus aureus.扁柏酚选择性增强四环素对金黄色葡萄球菌的抗菌活性。
Microbiol Spectr. 2023 Mar 21;11(2):e0320522. doi: 10.1128/spectrum.03205-22.
9
Can egg yolk antibodies terminate the CSBV infection in apiculture?蛋黄抗体能否终止养蜂业中的 CSBV 感染?
Virus Res. 2023 Apr 15;328:199080. doi: 10.1016/j.virusres.2023.199080. Epub 2023 Mar 6.
10
Hinokitiol for hypertensive emergencies: effects on peripheral resistance, cardiac load, baroreflex sensitivity, and electrolytes balance.荜澄茄醇治疗高血压危象:对周围阻力、心脏负荷、压力反射敏感性和电解质平衡的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2023 Jun;396(6):1269-1277. doi: 10.1007/s00210-023-02400-0. Epub 2023 Jan 30.

可能将桧木醇用作天然锌载体和抗感染剂,用于预防和治疗 COVID-19 和病毒感染。

A possible application of hinokitiol as a natural zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and viral infections.

机构信息

Department of Surgery, Nimni-Cordaba Tissue Engineering and Drug Discovery Laboratory, University of Southern California, Los Angeles, CA, USA.

出版信息

Med Hypotheses. 2020 Dec;145:110333. doi: 10.1016/j.mehy.2020.110333. Epub 2020 Oct 5.

DOI:10.1016/j.mehy.2020.110333
PMID:33045596
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7534793/
Abstract

Zinc and the combination with zinc ionophore have been reported in basic research and several clinical investigations as a potentially viable and economical preventive and therapeutic options for COVID-19 treatment. Zinc is a vital microelement that actively supports respiratory epithelium barrier integrity, innate and adaptive immune functions, and inflammatory regulations. Moreover, zinc may also prevent viral entry, suppress viral replication, and mitigate the damages due to oxidative stress and hyperinflammatory reaction in patients with respiratory infections. Hinokitiol (β-thujaplicin) is a natural monoterpenoid and is considered as a safe zinc ionophore to help zinc transport into cells. It has been widely used in skin and oral care, and therapeutic products for its potent antiviral, antimicrobial, antifungal, anti-inflammatory, and anticancer applications. The ongoing COVID-19 pandemic and the significant morbidity and mortality exist in the high-risk group of patients associated with other respiratory infections such as influenza, respiratory syncytial virus, and dengue fever. There is an urgent need for the development of inexpensive, safe, and effective therapeutics to prevent and treat these viral infections. Considering that hydroxychloroquine (HCQ), the most studied zinc ionophore drug for COVID-19, is linked to potentially serious side effects, we propose the implementation of hinokitiol as a zinc ionophore and anti-infective agent for the prevention and treatment of COVID-19 and other viral infections.

摘要

锌以及锌离子载体的联合应用已在基础研究和多项临床研究中被报道为 COVID-19 治疗中一种具有潜在可行性和经济性的预防和治疗选择。锌是一种重要的微量元素,它积极支持呼吸道上皮屏障的完整性、固有和适应性免疫功能以及炎症调节。此外,锌还可能预防病毒进入、抑制病毒复制,并减轻呼吸道感染患者因氧化应激和过度炎症反应而造成的损害。桧木醇(β-柏木脑)是一种天然单萜类化合物,被认为是一种安全的锌离子载体,有助于锌进入细胞的转运。它已广泛用于皮肤和口腔护理以及治疗产品,因其具有强效的抗病毒、抗菌、抗真菌、抗炎和抗癌作用。目前正在发生的 COVID-19 大流行以及与其他呼吸道感染(如流感、呼吸道合胞病毒和登革热)相关的高危患者群体中存在显著的发病率和死亡率。迫切需要开发廉价、安全和有效的治疗方法来预防和治疗这些病毒感染。鉴于羟氯喹(HCQ)是研究最多的 COVID-19 锌离子载体药物,与潜在的严重副作用相关,我们建议将桧木醇作为锌离子载体和抗感染剂用于 COVID-19 和其他病毒感染的预防和治疗。